Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Cielo vs Enhance MD

Cielo
Graded #121

Lower grade

vs+15.399999999999991
Enhance MD
Graded #11

Higher grade

The verdict

Enhance MD takes it — 84.8/100 to 69.4/100.

Enhance MD grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A transparently tiered compounded program — semaglutide $212/mo (first month $112), tirzepatide $280, a $169 microdose, and a $322 combo — backed by six-month lab testing and provider care, with NAD+ on the side.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEnhance MD +6
76
82
Dose & formulationCielo +3
85
82
Clinical oversightEnhance MD +9
79
88
Labs & monitoringEnhance MD +37
53
90
FulfillmentEnhance MD +17
67
84
Contract termsEnhance MD +64
20
84
Cielo · left barEnhance MD · right bar

The numbers

MetricCieloEnhance MD
WeighScore69.4/10084.8/100
GradeCB
Scorecard rank#121#11
Semaglutide$149/mo (all doses, compounded)$212/mo
Tirzepatide$249/mo (all doses, compounded)$280/mo
CoverageCoverage not publishedNot publicly listed
Brand-name accessYesCompounded only
Oral / sublingualInjection onlyInjection only
Cielo

Graded #121 · C

Strengths

  • Among the lowest 3-month bundle prices in compounded GLP-1 ($115/mo semaglutide)
  • Single flat price across all doses simplifies titration planning
  • Corporate address (St. Petersburg, FL) and customer-service phone published

Where it loses points

  • No LegitScript, NABP .pharmacy, or HIPAA badge on the home page
  • Pharmacy partner not named (only 'regulated FDA pharmacy partners')
  • State coverage list not published — can't verify all-50-state availability
  • Clinical care runs through MD Integrations, a shared third-party network used by many brands
  • No brand-name Wegovy or Zepbound option
Enhance MD

Graded #11 · B

Strengths

  • Transparent tiered pricing across sema, tirz, microdose, and combo
  • Dose-flat — the price does not step up as you titrate
  • Six-month lab testing plus provider-led care
  • NAD+ longevity adjacency available

Where it loses points

  • Compounded only — no brand-name Ozempic/Wegovy or Mounjaro/Zepbound
  • No oral or sublingual route
  • States served are not published
  • Higher entry price than the cheapest compounded programs

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard